STERIS (NYSE:STE) Shares Acquired Rep. April McClain Delaney

09 Apr 2026, 23:08 by Jessica Moore · The Cerbat Gem

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on March 16th.

Representative April McClain Delaney also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Somnigroup International (NYSE:SGI) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Nasdaq (NASDAQ:NDAQ) on 3/31/2026.
Sold $1,001 – $15,000 in shares of Bio-Techne (NASDAQ:TECH) on 3/26/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 3/20/2026.
Purchased $1,001 – $15,000 in shares of Nasdaq (NASDAQ:NDAQ) on 3/18/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 3/17/2026.
Purchased $1,001 – $15,000 in shares of Somnigroup International (NYSE:SGI) on 3/16/2026.

STERIS Stock Down 0.8%

Shares of STE traded down $1.71 on Thursday, hitting $223.32. 517,084 shares of the stock traded hands, compared to its average volume of 748,633. The company has a market capitalization of $21.90 billion, a PE ratio of 31.15 and a beta of 1.07. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The business has a 50 day simple moving average of $235.27 and a 200 day simple moving average of $246.99. STERIS plc has a one year low of $209.98 and a one year high of $269.44.

STERIS (NYSE:STE – Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were given a dividend of $0.63 per share. The ex-dividend date of this dividend was Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. STERIS’s dividend payout ratio (DPR) is 35.15%.

Analyst Ratings Changes

Several brokerages recently weighed in on STE. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 28th. Six analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, STERIS presently has an average rating of “Moderate Buy” and a consensus target price of $275.20.

View Our Latest Analysis on STERIS

Institutional Investors Weigh In On STERIS

Large investors have recently added to or reduced their stakes in the stock. Steigerwald Gordon & Koch Inc. bought a new stake in STERIS in the 3rd quarter worth approximately $25,000. Board of the Pension Protection Fund bought a new stake in STERIS in the 4th quarter worth approximately $25,000. Activest Wealth Management grew its position in STERIS by 423.8% in the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 89 shares during the period. Measured Wealth Private Client Group LLC bought a new stake in STERIS in the 4th quarter worth approximately $28,000. Finally, Harbor Investment Advisory LLC grew its position in STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 60 shares during the period. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling

In other news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the transaction, the director owned 705 shares in the company, valued at $167,233.05. This trade represents a 81.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.07% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About STERIS

(Get Free Report)

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.